ZS Pharma (ZSPH) Misses Q1 EPS by 19c

ZS Pharma (NASDAQ: ZSPH) reported Q1 EPS of ($1.05), $0.19 worse than the analyst estimate of ($0.86).

For earnings history and earnings-related data on ZS Pharma (ZSPH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c